Altium Capital Management LLC 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 3:47 pm Unchanged |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Altium Capital Management LLC | 194,100 4.990% |
0 (Unchanged) |
Filing |
| 2024-01-10 1:35 pm Purchase |
2023-12-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Altium Capital Management LLC | 194,100 8.000% |
194,100 (New Position) |
Filing |